subject: PUBCHEM.COMPOUND:16760419

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: kidney neoplasm

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:16760419

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:16760419

object_name: liver cancer


subject: PUBCHEM.COMPOUND:16760419

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:16760419

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:16760419

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:16760419

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:16760419

object_name: sarcoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:8499

subject_name: Propranolol

object_name: Childhood Soft Tissue Sarcoma

tested_intervention: yes


subject: CHEBI:8499

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:8499


subject: CHEBI:8499

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:8499

object_name: soft tissue sarcoma


subject: KEGG.COMPOUND:C02380

object_name: lymphoblastic lymphoma


subject: KEGG.COMPOUND:C02380

object_name: Adult Lymphoblastic Lymphoma


subject: KEGG.COMPOUND:C02380

object_name: Childhood Lymphoblastic Lymphoma


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab


subject: UNII:4FR53SIF3A


subject: UNII:4FR53SIF3A


subject: UMLS:C5211305

subject_name: CALASPARGASE

object_name: acute lymphoblastic leukemia


subject: UMLS:C5211305


subject: UMLS:C5211305


subject: UMLS:C5211305


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UMLS:C4530824


subject: UMLS:C4530824


subject: UMLS:C4530824


subject: UMLS:C4530824


subject: CHEBI:4614

subject_name: Dimethyl trisulfide

object_name: Post-Operative Pain


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Depressed mood


subject: UMLS:C0919079

object_name: Cancer patients and suicide and depression


subject: UMLS:C0919079

object_name: Depressed - symptom


subject: UMLS:C0919079

object_name: Depression, CTCAE


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:177833

subject_name: Cilengitide

object_name: non-small cell lung carcinoma


subject: UMLS:C0764377


subject: UMLS:C5445199

subject_name: Hydroxyprogesterone Caproate Liquid Injection

object_name: Premature birth


subject: HMDB:HMDB0032337

subject_name: Hydroxypropyl cellulose


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: complex regional pain syndrome


subject: CHEBI:3757

subject_name: Clonidine


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: neoplastic syndrome


subject: PUBCHEM.COMPOUND:6096882

object_name: neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: neoplastic disease or syndrome


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEMBL.COMPOUND:CHEMBL3707293

object_name: chronic obstructive pulmonary disease


subject: CHEBI:135954

subject_name: Bilastine

object_name: perennial allergic rhinitis


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: chronic hepatitis C virus infection


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C5962488

subject_name: Alpha-clash Anti-IL-2 Antibody Fusion Protein LAT010

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:151

subject_name: ISOCITRIC ACID


subject: UMLS:C4043590


subject: UMLS:C4043590

object_name: gonorrhea


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: recurrent primary peritoneal cavity cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: adult lymphoma


subject: UNII:YZS3R7LP44

object_name: lymphoma


subject: UNII:YZS3R7LP44

object_name: pediatric lymphoma


subject: UNII:YZS3R7LP44

object_name: leukemia


subject: UNII:YZS3R7LP44

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:135566117

subject_name: Aliqopa


subject: UMLS:C0487940

subject_name: Lb substance

object_name: Post-Operative Pain


subject: UMLS:C0487940

object_name: rotator cuff syndrome


subject: UMLS:C0487940

object_name: Rotator cuff tear


subject: CHEBI:9168

subject_name: Sirolimus

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:351346

subject_name: Phenethyl Isothiocyanate

object_name: lymphoproliferative syndrome


subject: CHEBI:351346


subject: CHEBI:351346


subject: UMLS:C5761789

object_name: Relapsed/refractory multiple myeloma


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: coccidioidomycosis


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:76567

subject_name: polyunsaturated fatty acid anion

object_name: type 2 diabetes mellitus


subject: UMLS:C0032615

subject_name: Polyunsaturated Fatty Acids


subject: CHEBI:26208

subject_name: polyunsaturated fatty acid


subject: UNII:CD7WXM716P

object_name: adrenal gland pheochromocytoma


subject: UNII:CD7WXM716P

object_name: pheochromocytoma


subject: UNII:CD7WXM716P

object_name: paraganglioma


subject: UMLS:C1098513

object_name: HIV infection


subject: UNII:9RV78Q2002

subject_name: Vedolizumab


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: cancer


subject: UNII:R8DG7T2D3A

object_name: neoplasm


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: neoplastic meningitis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:77260

subject_name: Omeprazole

object_name: bariatric surgery candidate


subject: GTOPDB:12652

subject_name: magrolimab

object_name: head and neck squamous cell carcinoma


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: CHEBI:4672

subject_name: Docetaxel

object_name: uterine cervix neoplasm


subject: CHEBI:91414

subject_name: Adavosertib


subject: CHEBI:91414


subject: UMLS:C4053677


subject: UMLS:C4053677


subject: UMLS:C2347419


subject: UMLS:C2347419


subject: UMLS:C3502775


subject: UMLS:C3502775


subject: CHEBI:231342

subject_name: ceralasertib


subject: CHEBI:231342


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: PUBCHEM.COMPOUND:42602260


subject: CHEBI:124917

subject_name: Rabusertib

object_name: Solid Neoplasm


subject: CHEBI:6801

subject_name: Metformin

object_name: Long segment Barrett's esophagus


subject: CHEBI:6801

object_name: Short segment Barrett's esophagus


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:77260


subject: CHEBI:77260


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UNII:26RU378B9V

object_name: ulcerative colitis


subject: UNII:26RU378B9V

object_name: inflammatory bowel disease 1


subject: CHEBI:50692

subject_name: Mifepristone

object_name: INTRAUTERINE FETAL DEMISE TERM


subject: CHEBI:50692

object_name: Gestation abnormality


subject: CHEBI:63610

subject_name: Misoprostol


subject: CHEBI:63610


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: female reproductive system disorder


subject: CHEBI:63610


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Reperfusion Injury


subject: PUBCHEM.COMPOUND:3962

object_name: Squamous cell carcinoma of head and neck metastatic


subject: PUBCHEM.COMPOUND:3962

object_name: Squamous cell carcinoma of head and neck recurrent


subject: PUBCHEM.COMPOUND:3962

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: PUBCHEM.COMPOUND:3962

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:3962

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:3962

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: PUBCHEM.COMPOUND:3962

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:3962

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: PUBCHEM.COMPOUND:3962

object_name: Metastatic Squamous Cell Carcinoma of the Nasopharynx


subject: PUBCHEM.COMPOUND:3962

object_name: Laryngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:3962

object_name: Metastatic Paranasal Sinus Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:3962

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:3962

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:3962

object_name: Recurrent Paranasal Sinus Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:3962

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3962

object_name: Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3962

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3962

object_name: Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary


subject: PUBCHEM.COMPOUND:3962

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:3962

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:3962

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:3962

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:40303

subject_name: Lovastatin

object_name: Squamous cell carcinoma of head and neck metastatic


subject: CHEBI:40303

object_name: Squamous cell carcinoma of head and neck recurrent


subject: CHEBI:40303

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: CHEBI:40303

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: CHEBI:40303

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:40303

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:40303

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:40303

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: CHEBI:40303

object_name: Metastatic Squamous Cell Carcinoma of the Nasopharynx


subject: CHEBI:40303

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:40303

object_name: Metastatic Paranasal Sinus Squamous Cell Carcinoma


subject: CHEBI:40303

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:40303

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:40303

object_name: Recurrent Paranasal Sinus Squamous Cell Carcinoma


subject: CHEBI:40303

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: CHEBI:40303

object_name: Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:40303

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:40303

object_name: Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:40303

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:40303

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:40303

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v8


subject: CHEBI:40303

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UNII:DPT0O3T46P

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UNII:DPT0O3T46P

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UNII:DPT0O3T46P

object_name: Metastatic Squamous Cell Carcinoma of the Nasopharynx


subject: UNII:DPT0O3T46P

object_name: Metastatic Paranasal Sinus Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:145818

subject_name: Bactroban Nasal

object_name: staphylococcal infection


subject: CHEBI:135905

subject_name: Terlipressin

object_name: esophageal varices


subject: CHEBI:135905

object_name: Hemorrhage


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: B-cell neoplasm


subject: UMLS:C1541395


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IB Breast Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Breast cancer stage II


subject: UNII:5TAA004E22

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIB Breast Carcinoma


subject: UNII:5TAA004E22

object_name: malignant neoplasm of breast stage IIb


subject: UNII:5TAA004E22

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Breast cancer stage III


subject: UNII:5TAA004E22

object_name: Stage III Breast Cancer AJCC v6


subject: UNII:5TAA004E22

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIA Breast Carcinoma


subject: UNII:5TAA004E22

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIA Breast Carcinoma


subject: UNII:5TAA004E22

object_name: Stage IIIB Breast Carcinoma


subject: UNII:5TAA004E22

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:5TAA004E22

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: HER2/Neu Negative


subject: UNII:5TAA004E22

object_name: One or More Positive Axillary Nodes


subject: UNII:5TAA004E22

object_name: No Evidence of Disease


subject: PR:000005931

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PR:000005931

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PR:000005931

object_name: Stage IB Breast Cancer AJCC v7


subject: PR:000005931

object_name: Breast cancer stage II


subject: PR:000005931

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PR:000005931

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PR:000005931

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PR:000005931

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: PR:000005931

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIB Breast Carcinoma


subject: PR:000005931

object_name: malignant neoplasm of breast stage IIb


subject: PR:000005931

object_name: Stage III Breast Cancer AJCC v7


subject: PR:000005931

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: PR:000005931

object_name: Breast cancer stage III


subject: PR:000005931

object_name: Stage III Breast Cancer AJCC v6


subject: PR:000005931

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: PR:000005931

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: PR:000005931

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIA Breast Carcinoma


subject: PR:000005931

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PR:000005931

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIA Breast Carcinoma


subject: PR:000005931

object_name: Stage IIIB Breast Carcinoma


subject: PR:000005931

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PR:000005931

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PR:000005931

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PR:000005931

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PR:000005931

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PR:000005931

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PR:000005931

object_name: HER2/Neu Negative


subject: PR:000005931

object_name: One or More Positive Axillary Nodes


subject: PR:000005931

object_name: No Evidence of Disease


subject: UMLS:C4287951

subject_name: pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Stage IB Breast Cancer AJCC v7


subject: UMLS:C4287951

object_name: Breast cancer stage II


subject: UMLS:C4287951

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C4287951

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Stage IIB Breast Carcinoma


subject: UMLS:C4287951

object_name: malignant neoplasm of breast stage IIb


subject: UMLS:C4287951

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C4287951

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Breast cancer stage III


subject: UMLS:C4287951

object_name: Stage III Breast Cancer AJCC v6


subject: UMLS:C4287951

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Stage IIA Breast Carcinoma


subject: UMLS:C4287951

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C4287951

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C4287951

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C4287951

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C4287951

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C4287951

object_name: HER2/Neu Negative


subject: UMLS:C4287951

object_name: One or More Positive Axillary Nodes


subject: UMLS:C4287951

object_name: No Evidence of Disease


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:49603


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:31236


subject: UMLS:C4087059

subject_name: NPC-12G Gel

object_name: neurofibromatosis


subject: UMLS:C4087059

object_name: neurofibromatosis 1


subject: UMLS:C4087059

object_name: neurofibroma


subject: UMLS:C4087059

object_name: neurofibromatosis type 1


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: acute pyelonephritis


subject: UMLS:C3540708

object_name: Complicated urinary tract infection


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C4482910

subject_name: meropenem / vaborbactam


subject: UMLS:C4482910


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: myasthenia gravis


subject: CHEBI:168396

object_name: Myasthenia Gravis, CTCAE


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:32181

subject_name: Tamibarotene

object_name: Alzheimer disease


subject: CHEBI:31236

object_name: familial hyperprolactinemia


subject: CHEBI:31236

object_name: acquired hyperprolactinemia


subject: CHEBI:31236

object_name: hyperprolactinemia


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: pituitary tumor


subject: CHEBI:17650

object_name: craniopharyngioma


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Postoperative Pain, Acute


subject: CHEBI:26710

subject_name: Sodium chloride


subject: UMLS:C5565957

object_name: cystic fibrosis


subject: CHEBI:6801

subject_name: Metformin

object_name: generalized anxiety disorder


subject: CHEBI:125628

subject_name: Alisertib

object_name: Solid Neoplasm


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:50275

object_name: adult lymphoma


subject: CHEBI:50275

object_name: lymphoma


subject: CHEBI:50275

object_name: pediatric lymphoma


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: diffuse large B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: Stomach cancer


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: malignant epithelial tumor of ovary


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: cervical cancer


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: Microsatellite Stable Colorectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: Richter syndrome


subject: CHEMBL.COMPOUND:CHEMBL5421689

object_name: Metastatic urothelial carcinoma


subject: UMLS:C5666942

subject_name: CBL-B Inhibitor NX-1607


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: UMLS:C5666942


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:37845

subject_name: growth hormone

object_name: spinal cord injury


subject: CHEBI:169956

subject_name: Gly-His


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UniProtKB:P12824

subject_name: GH_HCMVA Envelope glycoprotein H (sprot)


subject: PR:000007957

subject_name: gamma-glutamyl hydrolase


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: CHEBI:15640

subject_name: Leucovorin

object_name: graft versus host disease


subject: CHEBI:15640

object_name: plasma cell myeloma


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: triple-negative breast carcinoma


subject: GTOPDB:9592

object_name: Triple-Negative Breast Cancer Finding


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:85252

subject_name: synaptamide

object_name: Subfertility


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: UMLS:C5690469


subject: UMLS:C3492499

subject_name: xian ling gu bao

object_name: Childhood Breast Carcinoma


subject: UMLS:C3492499

object_name: breast carcinoma


subject: UMLS:C3492499

object_name: breast cancer


subject: UMLS:C3492499

object_name: osteoporosis


subject: UMLS:C3492499

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C3492499

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C3492499

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C4053828

subject_name: Zhongyao Fufang


subject: UMLS:C4053828


subject: UMLS:C4053828


subject: UMLS:C4053828


subject: UMLS:C4053828


subject: UMLS:C4053828


subject: UMLS:C4053828


subject: CHEBI:4911

subject_name: Etoposide

object_name: Lymphoma, Extranodal NK-T-Cell


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:83629

subject_name: tea tree oil

object_name: periodontitis


subject: DRUGBANK:DB11218

subject_name: Tea tree oil


subject: UNII:7GAF379J5J

subject_name: TOLL-LIKE RECEPTOR 9

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:7GAF379J5J

object_name: pancreatic neoplasm


subject: UNII:7GAF379J5J

object_name: exocrine pancreatic carcinoma


subject: UNII:7GAF379J5J

object_name: malignant pancreatic neoplasm


subject: CHEBI:78887

subject_name: Tirapazamine

object_name: Klatskin Tumor


subject: MESH:C000730795

object_name: Adverse effects


subject: UMLS:C0042210

subject_name: Vaccines

object_name: inflammatory bowel disease


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UNII:K45001587E

subject_name: Celivarone

object_name: atrial fibrillation


subject: UNII:K45001587E

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:K45001587E

object_name: Atrial Fibrillation, CTCAE


subject: UNII:K45001587E

object_name: atrial flutter


subject: UNII:K45001587E

object_name: Atrial Flutter by ECG Finding


subject: UNII:K45001587E

object_name: Atrial Flutter, CTCAE


subject: UMLS:C2350929


subject: UMLS:C2350929


subject: UMLS:C2350929


subject: UMLS:C2350929


subject: UMLS:C2350929


subject: UMLS:C2350929


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID

object_name: rheumatoid arthritis


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated


subject: UMLS:C5240006

subject_name: Vaccine product containing only acellular Bordetella pertussis antigen (medicinal product)


subject: CHEBI:18167

subject_name: alpha-maltose

object_name: functional gastric disease


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: CHEBI:68554

subject_name: Deferiprone

object_name: Acute myocardial infarction type 1


subject: CHEBI:25812

subject_name: Ozone

object_name: interstitial cystitis


subject: CHEBI:25812

object_name: Painful Bladder Syndrome


subject: CHEBI:5001

subject_name: Fenofibrate


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Ocular Graft Versus Host Disease


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:4975

subject_name: Famotidine

object_name: West syndrome


subject: CHEBI:4975

object_name: Infantile Spasm


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: UNII:F70C5K4786

subject_name: Melphalan flufenamide

object_name: Allergy


subject: UNII:F70C5K4786

object_name: hypersensitivity reaction disease


subject: UNII:F70C5K4786

object_name: Emotional hypersensitivity


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: marginal zone lymphoma


subject: UNII:D6OMY2L0WA

object_name: MALT lymphoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5417920

subject_name: Ivicentamab

object_name: high grade B-cell lymphoma


subject: UMLS:C5417920

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5417920

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C5417920

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C5417920

object_name: mantle cell lymphoma


subject: UMLS:C5417920

object_name: follicular lymphoma


subject: UMLS:C5417920

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5417920


subject: UMLS:C5417920


subject: UMLS:C5417920

object_name: primary mediastinal large B-cell lymphoma


subject: MESH:C054577

object_name: glucose intolerance


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: liver carcinoma


subject: CHEBI:23359

subject_name: colchicine

object_name: Microvascular coronary artery disease


subject: DRUGBANK:DB08937

object_name: colorectal cancer


subject: DRUGBANK:DB08937

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:90876

subject_name: Lonsurf


subject: CHEBI:90876


subject: UMLS:C4330704

object_name: eosinophilic gastroenteritis


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: osteoarthritis, knee


subject: UMLS:C1530450

subject_name: AMG 162


subject: MESH:C587029

subject_name: bu-yang-huan-wu-tang

object_name: Ischemic stroke


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: UMLS:C4688504

subject_name: FGFR4 Antagonist INCB062079


subject: UMLS:C4688504

object_name: cholangiocarcinoma


subject: UMLS:C4688504

object_name: nasopharyngeal carcinoma


subject: UMLS:C4688504

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C4688504

object_name: malignant tumor of nasopharynx


subject: UMLS:C4688504

object_name: carcinoma of esophagus


subject: UMLS:C4688504

object_name: esophageal cancer


subject: UMLS:C4688504

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4688504

object_name: neoplasm of esophagus


subject: UMLS:C4688504

object_name: ovarian cancer


subject: UMLS:C4688504

object_name: ovarian neoplasm


subject: UMLS:C4688504

object_name: ovarian carcinoma


subject: UMLS:C4688504

object_name: Solid Neoplasm


subject: UMLS:C5907985

subject_name: Androgen Receptor Inhibitor ONCT-534

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Stage 3 chronic kidney disease


subject: UMLS:C5575094

object_name: Angina pectoris


subject: DRUGBANK:DB05306

subject_name: Alferminogene tadenovec


subject: UNII:R30772KCU0

subject_name: Isatuximab

object_name: Paraproteinemia


subject: UMLS:C2983777


subject: UMLS:C2983777

object_name: monoclonal gammopathy of uncertain significance


subject: UMLS:C1312955

subject_name: talaporfin sodium

object_name: malignant soft tissue neoplasm


subject: UMLS:C1312955

object_name: sarcoma


subject: UMLS:C1312955

object_name: Pelvic Cancer


subject: UMLS:C1312955

object_name: rectal carcinoma


subject: UMLS:C1312955

object_name: rectal cancer


subject: UMLS:C1312955

object_name: Childhood Rectal Carcinoma


subject: UMLS:C1312955

object_name: colorectal cancer


subject: UMLS:C1312955

object_name: colorectal carcinoma


subject: UMLS:C1312955

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1312955

object_name: oral cavity carcinoma


subject: UMLS:C1312955

object_name: oral cavity cancer


subject: UMLS:C1312955

object_name: Childhood Breast Carcinoma


subject: UMLS:C1312955

object_name: breast carcinoma


subject: UMLS:C1312955

object_name: breast cancer


subject: UMLS:C1312955

object_name: Neck Carcinoma


subject: UMLS:C1312955

object_name: head and neck neoplasm


subject: UMLS:C1312955

object_name: head and neck cancer


subject: UMLS:C4527194

subject_name: Protease Inhibitor Formulation LB1148

object_name: ileus


subject: UMLS:C4527194

object_name: Ileus, CTCAE


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: plasma cell myeloma


subject: CHEBI:93755


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:3249

object_name: Inflammation


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product

object_name: type 2 diabetes mellitus


subject: UMLS:C3714696


subject: UMLS:C3714696


subject: UNII:F8Z9VSZ0K1

subject_name: RUNIMOTAMAB

object_name: Solid Neoplasm


subject: UMLS:C4745002


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UMLS:C0718234

subject_name: Acthar

object_name: proteinuria


subject: UMLS:C0718234

object_name: Proteinuria of undiagnosed cause


subject: UMLS:C0718234

object_name: Proteinuria, CTCAE 3.0


subject: UMLS:C0718234

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C0718234

object_name: Transplant glomerulopathy


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: Childhood Breast Carcinoma


subject: UNII:768FW21J3L

object_name: breast carcinoma


subject: UNII:768FW21J3L

object_name: breast cancer


subject: UNII:768FW21J3L

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5418043

subject_name: ADC SHR-A1811

object_name: Carcinoma breast stage IV


subject: UMLS:C5418043


subject: UMLS:C5785765


subject: UMLS:C5785765


subject: UMLS:C5785765


subject: UMLS:C5785765


subject: UMLS:C5785765


subject: UMLS:C5907971

subject_name: Anti-HER3 Antibody-drug Conjugate SHR-A2009

object_name: Advanced breast cancer


subject: UMLS:C5907971


subject: UMLS:C5907971


subject: UMLS:C5854493

subject_name: Anti-nectin-4 Antibody-drug Conjugate SHR-A2102


subject: UMLS:C5854493


subject: UMLS:C5854493


subject: UMLS:C5854493


subject: UMLS:C5854493


subject: UMLS:C5854493


subject: UMLS:C3465229

subject_name: Pertzye

object_name: Matthew-Wood syndrome


subject: UMLS:C3465229

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C3465229

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3465229

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C3465229

object_name: stage IV pancreatic cancer


subject: UMLS:C3465229

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C3465229

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3465229

object_name: pancreatic neoplasm


subject: UMLS:C3465229

object_name: malignant pancreatic neoplasm


subject: UMLS:C3465229

object_name: Pancreatic carcinoma non-resectable


subject: UMLS:C3465229

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3465229

object_name: Pancreatic cancer non-resectable


subject: CHEBI:231693

subject_name: Capmatinib

object_name: Advanced Hepatocellular Carcinoma


subject: GTOPDB:10140

subject_name: spartalizumab


subject: UNII:QOG25L6Z8Z


subject: UMLS:C4053607


subject: UNII:380F68J5PH

subject_name: Ilacirnon

object_name: type 2 diabetes mellitus


subject: UMLS:C2934194

subject_name: BI 1744 CL

object_name: asthma


subject: CHEBI:4995

subject_name: Felbamate

object_name: bipolar disorder


subject: UMLS:C1533712

subject_name: Heparanase inhibitor PI-88

object_name: cancer


subject: UMLS:C1533712

object_name: neoplasm


subject: UMLS:C1533712

object_name: liver cancer


subject: UMLS:C1533712

object_name: liver neoplasm


subject: UMLS:C1533712

object_name: Adult Liver Carcinoma


subject: UMLS:C1533712

object_name: liver carcinoma


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Angina pectoris


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Unspecified injury of ankle and foot


subject: CHEBI:7852

subject_name: Oxycodone


subject: UMLS:C2698852

subject_name: Pomegranate Liquid Extract

object_name: prostate carcinoma


subject: UMLS:C2698852

object_name: prostate cancer


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: cyclic vomiting syndrome


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: alveolar rhabdomyosarcoma


subject: UNII:2285XW22DR

object_name: Childhood Embryonal Rhabdomyosarcoma


subject: UNII:2285XW22DR

object_name: Untreated Childhood Rhabdomyosarcoma


subject: UNII:2285XW22DR

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:2285XW22DR

object_name: Stage IV adult soft tissue sarcoma


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:125400

subject_name: actinomycin D


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:91872

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:87681

subject_name: Ranolazine

object_name: myocardial stunning


subject: UMLS:C4303996

subject_name: Snake antivenom immunoglobulin

object_name: Toxic effect of venom


subject: UMLS:C4303996

object_name: Snakebite Envenoming


subject: DRUGBANK:DB10516

subject_name: Casein

object_name: Inflammation


subject: UMLS:C0026138

subject_name: Milk Proteins


subject: MESH:D056692

subject_name: Prebiotics


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:31296

subject_name: Blonanserin

object_name: schizophrenia


subject: RXCUI:1656336

subject_name: sacubitril / valsartan Oral Product

object_name: hypertension


subject: RXCUI:1656336

object_name: Hypertension, CTCAE


subject: CHEBI:74076

subject_name: Ile-Pro

object_name: ovarian cancer


subject: CHEBI:74076

object_name: ovarian neoplasm


subject: CHEBI:74076

object_name: ovarian carcinoma


subject: CHEBI:82335


subject: CHEBI:82335


subject: CHEBI:82335


subject: CHEBI:17660

subject_name: ENADENINE


subject: CHEBI:17660


subject: CHEBI:17660


subject: UMLS:C4049997


subject: UMLS:C4049997


subject: UMLS:C4049997


subject: PR:000014564

subject_name: succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial


subject: PR:000014564


subject: PR:000014564


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Nausea, CTCAE_5


subject: PUBCHEM.COMPOUND:521372

object_name: Nausea


subject: PUBCHEM.COMPOUND:521372

object_name: Nausea, CTCAE_3


subject: PUBCHEM.COMPOUND:521372

object_name: lean body mass


subject: PUBCHEM.COMPOUND:521372

object_name: cannabis abuse


subject: PUBCHEM.COMPOUND:521372

object_name: Cachexia


subject: PUBCHEM.COMPOUND:521372

object_name: Vomiting


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:68646

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: malaria


subject: CHEBI:28796

subject_name: fructan

object_name: irritable bowel syndrome


subject: CHEBI:28645

subject_name: FRUCTOSE


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: pervasive developmental disorder


subject: CHEBI:127342

object_name: autism


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: adult dermatomyositis


subject: CHEBI:71200

object_name: dermatomyositis


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:6504

object_name: neuralgia


subject: CHEBI:6504

object_name: Neuropathic pain


subject: CHEBI:6504

object_name: Neuralgia, CTCAE


subject: UMLS:C4042170

object_name: marginal zone lymphoma


subject: UMLS:C4042170

object_name: MALT lymphoma


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: lung cancer


subject: UMLS:C4083270

object_name: lung neoplasm


subject: UMLS:C4083270

object_name: lung carcinoma


subject: CHEBI:91400

subject_name: Afatinib


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:35677

subject_name: Betahistine

object_name: Hypercholesterolemia


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: CHEBI:25567

subject_name: Nitrous acid

object_name: cardiac arrest


subject: CHEBI:25567

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:16301

subject_name: Nitrite


subject: CHEBI:16301


subject: CHEBI:149681

subject_name: methcathinone

object_name: Cat Allergy


subject: CHEBI:149677

subject_name: Methcathinone


subject: CHEBI:32402


subject: UMLS:C0042210

subject_name: Vaccines

object_name: herpes zoster


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: PUBCHEM.COMPOUND:135565128

subject_name: Fimaporfin

object_name: cholangiocarcinoma


subject: DRUGBANK:DB17253


subject: CHEBI:79042

subject_name: Tasimelteon

object_name: endogenous depression


subject: CHEBI:79042

object_name: major depressive disorder


subject: CHEBI:91899


subject: CHEBI:91899


subject: CHEBI:91899


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:42446

subject_name: Esflurbiprofen

object_name: Pancreatic stone disease


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:8802

subject_name: Remifentanil


subject: UNII:V7YQ6134AE

object_name: nonpapillary renal cell carcinoma


subject: UNII:V7YQ6134AE

object_name: clear cell renal carcinoma


subject: UNII:V7YQ6134AE

object_name: renal cell adenocarcinoma


subject: UNII:V7YQ6134AE

object_name: renal cell carcinoma


subject: CHEBI:132922

object_name: Alzheimer disease


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Malignant melanoma of skin of breast


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Embolism, Tumor


subject: CHEBI:63605

object_name: Neoplasm Metastasis


subject: CHEBI:63605

object_name: Metastatic Lesion


subject: CHEBI:650917

object_name: Cachexia


subject: CHEBI:650917

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:650917


subject: CHEBI:650917

object_name: central nervous system cancer


subject: CHEBI:650917

object_name: Myelodysplasia


subject: CHEBI:650917

object_name: brain neoplasm


subject: CHEBI:650917

object_name: adult lymphoma


subject: CHEBI:650917

object_name: lymphoma


subject: CHEBI:650917

object_name: pediatric lymphoma


subject: CHEBI:650917

object_name: leukemia


subject: CHEBI:650917

object_name: childhood leukemia


subject: CHEBI:4046

subject_name: Cyproheptadine


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:4046


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:3080587


subject: UMLS:C3252897

subject_name: TAK 491

object_name: hypertension


subject: UMLS:C3252897

object_name: Hypertension, CTCAE


subject: GTOPDB:9615

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:9615

object_name: acute myeloid leukemia


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: CHEBI:2663

subject_name: Amiodarone

object_name: Chagas cardiomyopathy


subject: CHEBI:2663

object_name: Non-sustained ventricular tachycardia


subject: CHEBI:233321

subject_name: Mitoquinone

object_name: breast neoplasm


subject: CHEBI:137359

object_name: Complication of dialysis


subject: CHEBI:137359

object_name: end stage renal failure


subject: CHEBI:137359

object_name: Chronic uremia


subject: CHEBI:137359

object_name: chronic kidney disease


subject: CHEBI:137359

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:137359

object_name: Muscle Atrophy


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: UMLS:C2745432

subject_name: Meditoxin

object_name: Primary focal hyperhidrosis of axilla


subject: UNII:2Z03364G96

subject_name: Dapansutrile

object_name: melanoma


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: cardiogenic shock


subject: UNII:N02W67RKJS

object_name: colon carcinoma


subject: UNII:N02W67RKJS

object_name: colorectal cancer


subject: UNII:N02W67RKJS

object_name: colon cancer


subject: UNII:P28BIW0UTB

subject_name: FODIPIR


subject: UNII:P28BIW0UTB


subject: UNII:P28BIW0UTB


subject: PUBCHEM.COMPOUND:76967443

subject_name: Mangafodipir


subject: PUBCHEM.COMPOUND:76967443


subject: PUBCHEM.COMPOUND:76967443


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: Pregnant


subject: HMDB:HMDB0001349

object_name: Hashimoto thyroiditis


subject: HMDB:HMDB0001349

object_name: autoimmune thyroid disease


subject: HMDB:HMDB0001349

object_name: infertility


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: CHEBI:78543

subject_name: Ponatinib

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C0127159

subject_name: MCI 186

object_name: kidney failure


subject: CHEBI:31530

subject_name: Edaravone


subject: UMLS:C2983764

object_name: renal carcinoma


subject: UMLS:C2983764

object_name: kidney neoplasm


subject: UMLS:C2983764

object_name: kidney cancer


subject: CHEBI:231693

subject_name: Capmatinib


subject: CHEBI:231693


subject: CHEBI:231693


subject: CHEBI:50131

subject_name: Decitabine

object_name: Pancreatic adenocarcinoma recurrent


subject: CHEBI:50131

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C1569281

subject_name: Cerazette

object_name: Hemorrhage


subject: CHEBI:4453

subject_name: Desogestrel


subject: CHEBI:50777

subject_name: Etonogestrel


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: urinary system disorder


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Coronavinae infectious disease


subject: UMLS:C2718754

subject_name: Ilaris


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Cooley's anemia


subject: UNII:4EQZ6YO2HI

object_name: beta thalassemia


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C4726567

subject_name: Acyclic Nucleoside Phosphonate Prodrug ABI-1968

object_name: HIV infection


subject: UMLS:C4726567

object_name: High-Grade Squamous Intraepithelial Lesions


subject: UMLS:C4726567

object_name: human papilloma virus infection


subject: UMLS:C4726567

object_name: anus cancer


subject: UMLS:C4726567

object_name: anal carcinoma


subject: UMLS:C4726567

object_name: anus neoplasm


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: Lymphadenitis due to Wuchereria bancrofti


subject: CHEBI:6078

subject_name: Ivermectin


subject: UNII:4613T5ZY7G

subject_name: inosine dialdehyde

object_name: filarial elephantiasis


subject: UNII:4613T5ZY7G


subject: CHEBI:24786

subject_name: iminodiacetic acid


subject: CHEBI:24786


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: UMLS:C2700272

subject_name: White Button Mushroom Extract

object_name: prostate carcinoma


subject: UMLS:C2700272

object_name: prostate cancer


subject: CHEBI:68551

subject_name: Linaclotide

object_name: Functional constipation


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C0919144

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C0919144

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C0919144

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C0919144

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UMLS:C0376562

subject_name: Recombinant Granulocyte Colony Stimulating Factor


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C0376562


subject: UMLS:C3274580

subject_name: Yttrium Y 90 Basiliximab


subject: UMLS:C3274580


subject: UMLS:C3274580


subject: UMLS:C3274580


subject: UMLS:C3274580


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: History of liver recipient


subject: CHEBI:46195

object_name: Liver transplant recipient


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:74078

subject_name: Ile-Ser


subject: CHEBI:74078


subject: CHEBI:7459

subject_name: Naloxone

object_name: binge eating


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:5801

object_name: clear cell renal carcinoma


subject: CHEBI:5801

object_name: renal cell adenocarcinoma


subject: CHEBI:5801

object_name: renal cell carcinoma


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: PR:000004904

subject_name: complement C5


subject: PR:000004904


subject: PR:000004904


subject: PR:000004904


subject: UMLS:C3885071

object_name: respiratory syncytial virus infectious disease


subject: PR:000004930

subject_name: calcineurin-binding protein cabin-1

object_name: graft versus host disease


subject: CHEBI:119915

subject_name: Fentanyl

object_name: nasopharyngeal carcinoma


subject: CHEBI:119915

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:119915

object_name: Neck Carcinoma


subject: CHEBI:119915

object_name: head and neck neoplasm


subject: CHEBI:119915

object_name: head and neck cancer


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: superficial urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: UMLS:C3658787


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Prediabetes


subject: CHEBI:40279

object_name: Insulin resistance


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Ureteral Calculi


subject: CHEBI:6456

object_name: ureterolithiasis


subject: CHEBI:6456

object_name: nephrolithiasis


subject: CHEBI:6456

object_name: Renal Calculi, CTCAE


subject: UNII:T1NAO7YDA7

subject_name: VEREKITUG

object_name: chronic rhinosinusitis with nasal polyps


subject: UMLS:C5909037

subject_name: Verekitug


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:131769963

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: childhood bladder carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Accident caused by earthquake


subject: PUBCHEM.COMPOUND:435949

object_name: Amputated structure (morphologic abnormality)


subject: PUBCHEM.COMPOUND:435949

object_name: Phantom Limb


subject: PUBCHEM.COMPOUND:435949

object_name: Phantom Limb Pain


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:74327


subject: CHEBI:132082

subject_name: Entinostat

object_name: melanoma


subject: CHEBI:16946

subject_name: Kynurenine

object_name: Headache


subject: CHEBI:16946

object_name: Headache, CTCAE


subject: UMLS:C0022818


subject: UMLS:C0022818


subject: CHEBI:92607

subject_name: Methylergometrine

object_name: Uterine atony with hemorrhage


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C3898831

object_name: Stage III Prostate Cancer AJCC v8


subject: UMLS:C3898831

object_name: Stage IIB Prostate Cancer AJCC v8


subject: UMLS:C3898831

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UMLS:C3898831

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UMLS:C3898831

object_name: Stage IIIC Prostate Cancer AJCC v8


subject: UMLS:C3898831

object_name: Stage IIIB Prostate Cancer AJCC v8


subject: UMLS:C3898831

object_name: Stage IIIA Prostate Cancer AJCC v8


subject: UMLS:C3898831

object_name: PSA Level Greater than Ten


subject: CHEBI:50848

subject_name: Loteprednol

object_name: Posterior blepharitis


subject: CHEBI:73678


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:90942

subject_name: Ixazomib

object_name: smoldering plasma cell myeloma


subject: PUBCHEM.COMPOUND:5320784

subject_name: Pterosin E

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:5320784

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: human papillomavirus-related squamous cell carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:31355

subject_name: Carboplatin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Human Papilloma Virus, Female


subject: UNII:PVI5M0M1GW

object_name: Human Papilloma Virus, Male


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: squamous cell carcinoma


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423


subject: CHEBI:44423

object_name: head and neck squamous cell carcinoma


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C4725831

subject_name: Anti-CD40 Agonist Monoclonal Antibody CDX-1140

object_name: Recurrent ovarian cancer


subject: UMLS:C4725831

object_name: Recurrent Ovarian Clear Cell Adenocarcinoma


subject: UMLS:C4725831

object_name: Recurrent Ovarian Serous Adenocarcinoma


subject: UMLS:C4725831

object_name: Recurrent Ovarian Endometrioid Adenocarcinoma


subject: UMLS:C4725831

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C4725831

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: UMLS:C4725831

object_name: ovarian clear cell adenocarcinoma


subject: UMLS:C4725831

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C4725831

object_name: Recurrent Endometrial Serous Adenocarcinoma


subject: UMLS:C4725831

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C4725831

object_name: Recurrent Primary Peritoneal Clear Cell Adenocarcinoma


subject: UMLS:C4725831

object_name: Recurrent Fallopian Tube Endometrioid Adenocarcinoma


subject: UMLS:C4725831

object_name: Recurrent Primary Peritoneal Serous Adenocarcinoma


subject: UMLS:C4725831

object_name: Recurrent Primary Peritoneal Endometrioid Adenocarcinoma


subject: CHEBI:2663

subject_name: Amiodarone

object_name: atrial fibrillation new onset


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: brain injury


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Mechanical ventilation finding


subject: UMLS:C1452684

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C1452684

object_name: acute myeloid leukemia


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: liver carcinoma


subject: UMLS:C4331912


subject: CHEMBL.COMPOUND:CHEMBL5315001

subject_name: TOBEMSTOMIG


subject: UMLS:C5417992

subject_name: Tobemstomig


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Disorder related to renal transplantation


subject: PUBCHEM.COMPOUND:75905632

subject_name: flavocoxid

object_name: osteoarthritis


subject: CHEMBL.COMPOUND:CHEMBL5095276

subject_name: FLAVOCOXID


subject: UMLS:C1616742


subject: DRUGBANK:DB16507

object_name: avian influenza


subject: DRUGBANK:DB16507

object_name: influenza A subtype H5N1 infection


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: autism spectrum disorder


subject: CHEBI:6456

subject_name: Lidocaine

object_name: endometriosis


subject: UMLS:C2703131

subject_name: CAL 101

object_name: Atopic rhinitis


subject: UMLS:C2703131

object_name: Allergic Rhinitis, CTCAE


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib


subject: PUBCHEM.COMPOUND:11654566


subject: CHEBI:74076

subject_name: Ile-Pro

object_name: small cell lung carcinoma


subject: CHEBI:82335


subject: CHEBI:17660

subject_name: ENADENINE


subject: UMLS:C4049997


subject: PR:000014564

subject_name: succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial


subject: GTOPDB:12990

subject_name: sintilimab

object_name: non-small cell squamous lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C1509017

subject_name: INJECTION, VERTEPORFIN, 0.1 MG ADMINISTERED

object_name: prostate carcinoma


subject: UMLS:C1509017

object_name: prostate cancer


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: UMLS:C5706533

subject_name: ALK/ROS1 Inhibitor TGRX-326

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:64987

object_name: HIV-1 infection


subject: UMLS:C0445115

subject_name: Normal saline

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0445115

object_name: obesity


subject: UMLS:C0445115

object_name: Obesity, CTCAE


subject: CHEBI:16349

subject_name: Citrulline

object_name: type 2 diabetes mellitus


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:70839

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:70839

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:70839

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:70839

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:42588

subject_name: Fenretinide

object_name: adult glioblastoma


subject: CHEBI:42588

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:42588

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:42588

object_name: Adult Gliosarcoma


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor

object_name: Non-Erosive Reflux Disease


subject: CHEBI:49200

object_name: Heartburn


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: UMLS:C3536754


subject: CHEMBL.COMPOUND:CHEMBL3989780

subject_name: SUCRALFATE


subject: CHEMBL.COMPOUND:CHEMBL3989780


subject: GTOPDB:7055

subject_name: sucralfate


subject: GTOPDB:7055


subject: GTOPDB:8928

subject_name: pamrevlumab

object_name: Duchenne muscular dystrophy


subject: CHEMBL.COMPOUND:CHEMBL2109377

subject_name: PAMREVLUMAB


subject: UMLS:C2985186


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: HIV infection


subject: CHEBI:41500

subject_name: Phenylbutyrates


subject: UNII:5X5HB3VZ3Z

subject_name: Apricoxib

object_name: Childhood Breast Carcinoma


subject: UNII:5X5HB3VZ3Z

object_name: breast carcinoma


subject: UNII:5X5HB3VZ3Z

object_name: breast cancer


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C3827082


subject: UNII:BW5QA5GEW7

object_name: Carcinoma breast stage IV


subject: UNII:BW5QA5GEW7

object_name: non-small cell lung carcinoma


subject: UNII:BW5QA5GEW7


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide


subject: PUBCHEM.COMPOUND:121489720


subject: CHEBI:68534

subject_name: Enzalutamide


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: CHEBI:4910

subject_name: Etomidate

object_name: acute respiratory failure


subject: CHEMBL.COMPOUND:CHEMBL55643

subject_name: COPPER

object_name: Alzheimer disease


subject: CHEBI:28694

subject_name: Copper


subject: CHEBI:29036

subject_name: Cupric cation


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Sepsis


subject: UNII:LKC0U3A8NJ

object_name: Sepsis, CTCAE


subject: CHEBI:135010

subject_name: Enoximone

object_name: heart failure


subject: CHEBI:135010

object_name: congestive heart failure


subject: UNII:IZT740JY57

object_name: melanoma


subject: UMLS:C3501154


subject: CHEBI:83766

subject_name: Olaparib

object_name: High-Risk Cancer


subject: UMLS:C1138626

subject_name: cocoa extract

object_name: cardiovascular disorder


subject: UMLS:C1138626

object_name: glucose metabolism disease


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: DRUGBANK:DB10977


subject: PR:000004970

subject_name: calcium-binding and coiled-coil domain-containing protein 1


subject: PR:000004970


subject: UMLS:C0939909

subject_name: Theobroma cacao, cocoa, chocolate


subject: UMLS:C0939909


subject: DRUGBANK:DB10654

subject_name: Hazelnut


subject: DRUGBANK:DB10654


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: endometrial cancer


subject: CHEBI:73604

object_name: uterine corpus cancer


subject: CHEBI:73604

object_name: endometrial carcinoma


subject: CHEBI:73604

object_name: ovarian cancer


subject: CHEBI:73604

object_name: ovarian neoplasm


subject: CHEBI:73604

object_name: ovarian carcinoma


subject: CHEBI:73604

object_name: fallopian tube carcinoma


subject: CHEBI:73604

object_name: fallopian tube cancer


subject: CHEBI:73604

object_name: peritoneal neoplasm


subject: CHEBI:50853

subject_name: quantum dot


subject: CHEBI:50853


subject: CHEBI:50853


subject: CHEBI:50853


subject: CHEBI:50853


subject: CHEBI:50853


subject: CHEBI:50853


subject: CHEBI:50853


subject: CHEBI:50853


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: prostate neoplasm


subject: CHEBI:89324

object_name: BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UNII:P93RUU11P7

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: CHEBI:133021

subject_name: Venetoclax


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: EXCESS LMW-DNA


subject: PUBCHEM.COMPOUND:2735

object_name: lupus vulgaris


subject: PUBCHEM.COMPOUND:2735

object_name: lupus erythematosus


subject: PUBCHEM.COMPOUND:2735

object_name: discoid lupus erythematosus


subject: PUBCHEM.COMPOUND:2735

object_name: st. Louis encephalitis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: UNII:52CMI0WC3Y

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C5964899

subject_name: DIACYLGLYCEROL OIL

object_name: type 2 diabetes mellitus


subject: UMLS:C5964899

object_name: cardiovascular disorder


subject: UMLS:C5964899

object_name: Insulin Sensitivity


subject: PUBCHEM.COMPOUND:544190

object_name: avian influenza


subject: CHEBI:7798

subject_name: Oseltamivir


subject: CHEBI:7772

subject_name: omeprazole

object_name: bile reflux


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: chronic rhinosinusitis


subject: UMLS:C0910794


subject: DRUGBANK:DB11333

subject_name: Poloxamer 188

object_name: Acute limb ischaemia


subject: CHEBI:145924

subject_name: Kaletra

object_name: hepatitis B


subject: UMLS:C0939237

subject_name: lopinavir / ritonavir


subject: CHEBI:176724

subject_name: Etiracetam

object_name: oromandibular dystonia


subject: CHEBI:176724

object_name: Dystonia of head


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: Frontotemporal degeneration


subject: UMLS:C0378942


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin


subject: PR:000001379


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: euthyroid Graves orbitopathy


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban

object_name: blood coagulation disease


subject: PUBCHEM.COMPOUND:11635624

object_name: hemorrhagic disease


subject: UMLS:C4287755

subject_name: HER-Vaxx

object_name: Stomach cancer


subject: UMLS:C4287755

object_name: gastric cancer


subject: UMLS:C4287755


subject: UMLS:C4287755

object_name: gastric adenocarcinoma


subject: UMLS:C5222497

subject_name: Ropivacaine Hydrochloride Liquid Injection

object_name: Fused vertebrae


subject: UMLS:C5222497

object_name: Fusion of spine (disease)


subject: UMLS:C5222497

object_name: lumbar spinal stenosis


subject: UMLS:C5222497

object_name: spinal stenosis


subject: UMLS:C5222497

object_name: Disorder of lumbar spine


subject: UMLS:C5222497

object_name: Lumbar spondylosis


subject: UMLS:C5222497

object_name: lumbar disk disease


subject: UMLS:C5222497

object_name: lumbar disk degenerative disorder


subject: UMLS:C5222497

object_name: Lumbar spondylolisthesis


subject: UMLS:C5222497

object_name: lumbar disc herniation


subject: UMLS:C5222497

object_name: spondylosis lumbosacral region


subject: UMLS:C5222497

object_name: Lumbar radiculitis


subject: UMLS:C5222497

object_name: spondylolisthesis


subject: UMLS:C5222497

object_name: Congenital spondylolisthesis


subject: UMLS:C5222497

object_name: Acquired spondylolisthesis


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:60802


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Rhabdomyolysis Related to COVID-19


subject: CHEBI:41879

object_name: Rhabdomyolysis, CTCAE


subject: CHEBI:41879

object_name: Rhabdomyolysis


subject: CHEBI:75722

subject_name: Tramadol

object_name: substance withdrawal syndrome


subject: CHEBI:184910

subject_name: Rotigotine

object_name: Apathy


subject: CHEBI:184910

object_name: On examination - apathetic


subject: UNII:724QD330RD

subject_name: Abituzumab

object_name: metastatic colorectal cancer


subject: UNII:8202AY8I7H

subject_name: Eptinezumab


subject: UMLS:C2830088


subject: CHEBI:24261

subject_name: glucocorticoid

object_name: heart failure


subject: CHEBI:24261

object_name: Heart Failure, CTCAE


subject: CHEBI:45716

subject_name: Vorinostat

object_name: uveal melanoma


subject: CHEBI:45716

object_name: iris melanoma


subject: CHEBI:45716

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:45716

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:45716

object_name: metastatic melanoma


subject: CHEBI:45716

object_name: Melanoma recurrent


subject: CHEBI:45716

object_name: Recurrent Uveal Melanoma


subject: CHEBI:45716

object_name: medium/large size posterior uveal melanoma


subject: CHEBI:45716

object_name: ocular melanoma with extraocular extension


subject: CHEBI:28918

subject_name: Epinephrine

object_name: cardiogenic shock


subject: CHEBI:194548

subject_name: Racepinephrine


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Adolescent Obesity


subject: GTOPDB:12417

subject_name: abelacimab

object_name: venous thromboembolism


subject: GTOPDB:12417

object_name: thrombophilia due to thrombin defect


subject: GTOPDB:12417

object_name: Deep Venous Thrombosis Related to COVID-19


subject: GTOPDB:12417

object_name: Deep venous thrombosis


subject: GTOPDB:12417

object_name: pulmonary embolism


subject: UNII:KX1N4TV7UY


subject: UNII:KX1N4TV7UY


subject: UNII:KX1N4TV7UY


subject: UNII:KX1N4TV7UY


subject: UNII:KX1N4TV7UY


subject: UMLS:C5226842


subject: UMLS:C5226842


subject: UMLS:C5226842


subject: UMLS:C5226842


subject: UMLS:C5226842


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: traumatic encephalopathy


subject: CHEBI:231342

subject_name: ceralasertib

object_name: endometrial cancer


subject: CHEBI:231342

object_name: uterine corpus cancer


subject: CHEBI:231342

object_name: endometrial carcinoma


subject: CHEBI:231342

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:231342

object_name: clear cell renal carcinoma


subject: CHEBI:231342

object_name: Metastatic urothelial carcinoma


subject: CHEBI:231342

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:231342

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:231342

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:231342

object_name: stage IV pancreatic cancer


subject: CHEBI:231342

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:231342

object_name: Stage IV Renal Cell Cancer


subject: CHEBI:231342

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: CHEBI:231342

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:231342

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:231342

object_name: Pancreatic carcinoma stage III


subject: CHEBI:231342

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:231342

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:231342

object_name: Stage III renal cell cancer


subject: CHEBI:231342

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:231342

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:231342

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:231342

object_name: Locally Advanced Malignant Solid Neoplasm


subject: CHEBI:231342

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Metastatic urothelial carcinoma


subject: UNII:28X28X9OKV

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:28X28X9OKV

object_name: Metastatic Renal Cell Cancer


subject: UNII:28X28X9OKV

object_name: stage IV pancreatic cancer


subject: UNII:28X28X9OKV

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IV Renal Cell Cancer


subject: UNII:28X28X9OKV

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Pancreatic carcinoma stage III


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:83766

object_name: clear cell renal carcinoma


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:83766

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:83766

object_name: Stage III renal cell cancer


subject: CHEBI:83766

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C1254351

subject_name: Pharmacologic Substance

object_name: adult lymphoma


subject: UMLS:C1254351

object_name: lymphoma


subject: UMLS:C1254351

object_name: pediatric lymphoma


subject: UMLS:C5556793

subject_name: Recombinant Human Papillomavirus 14-valent Vaccine SCT1000

object_name: Prevention problem


subject: CHEMBL.COMPOUND:CHEMBL5314974

object_name: Heartburn


subject: CHEMBL.COMPOUND:CHEMBL5314974

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C5853404


subject: UMLS:C5853404


subject: MESH:C000708202

object_name: liver carcinoma


subject: MESH:C000708202

object_name: liver neoplasm


subject: UMLS:C4049148


subject: UMLS:C4049148


subject: CHEBI:7772

subject_name: omeprazole

object_name: Depressed mood


subject: CHEBI:7772

object_name: Cancer patients and suicide and depression


subject: CHEBI:7772

object_name: Depressed - symptom


subject: CHEBI:7772

object_name: Depression, CTCAE


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:156296

object_name: Unresectable Melanoma


subject: CHEBI:156296

object_name: melanoma


subject: CHEBI:156296

object_name: skin melanoma


subject: PUBCHEM.COMPOUND:3084049

subject_name: hyaluronan

object_name: osteoarthritis, hip


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:132153

subject_name: hyaluronate


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:85994

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C4721874

subject_name: human insulin

object_name: hyperglycemia


subject: UMLS:C0306371

subject_name: Humulin R


subject: UMLS:C1174887

object_name: interstitial lung disease 1


subject: UMLS:C1174887

object_name: interstitial lung disease 2


subject: CHEBI:30769

subject_name: Citric acid

object_name: Intrabony periodontal defect


subject: CHEBI:71940

subject_name: Tadalafil

object_name: Prediabetes


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron


subject: PUBCHEM.COMPOUND:18319735

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:18319735

object_name: obesity


subject: PUBCHEM.COMPOUND:18319735

object_name: Obesity, CTCAE


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: cutaneous leishmaniasis


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: Mesothelioma


subject: UNII:MRL3739G66

object_name: mesothelial neoplasm


subject: UNII:MRL3739G66

object_name: malignant mesothelioma


subject: UNII:MRL3739G66

object_name: thymoma


subject: UNII:MRL3739G66

object_name: thymus neoplasm


subject: CHEBI:83766

subject_name: Olaparib

object_name: neuroendocrine neoplasm


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:73044

subject_name: Lumiracoxib

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: cardiovascular disorder


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: stomach disease


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:91899

object_name: diarrhea


subject: CHEBI:91899

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:91899

object_name: Diarrhea, CTCAE


subject: CHEBI:91899

object_name: lymphocytic colitis


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:16796

subject_name: Melatonin

object_name: neonatal sepsis


subject: CHEBI:16796

object_name: Bacterial sepsis of newborn


subject: UMLS:C5417780

subject_name: KRT 232

object_name: acquired polycythemia vera


subject: DRUGBANK:DB16369

subject_name: Matrix-M

object_name: Malaria, Vivax


subject: CHEBI:28729

subject_name: alpha-D-mannose

object_name: Recurrent urinary tract infections


subject: CHEBI:28729

object_name: History of recurrent urinary tract infection


subject: CHEBI:28729

object_name: urinary tract infection


subject: CHEBI:28729

object_name: Lower urinary tract infectious disease


subject: CHEBI:28729

object_name: Recurrent cystitis


subject: CHEBI:28729

object_name: bacterial urinary tract infection


subject: CHEBI:28729

object_name: chronic cystitis


subject: CHEBI:16024

subject_name: D-mannose


subject: CHEBI:16024


subject: CHEBI:16024


subject: CHEBI:16024


subject: CHEBI:16024


subject: CHEBI:16024


subject: CHEBI:16024


subject: CHEBI:4208

subject_name: D-mannopyranose


subject: CHEBI:4208


subject: CHEBI:4208


subject: CHEBI:4208


subject: CHEBI:4208


subject: CHEBI:4208


subject: CHEBI:4208


subject: UMLS:C2912239

subject_name: Norditropin FlexPro Pen

object_name: hereditary endocrine growth disease


subject: CHEBI:6121

subject_name: Ketamine

object_name: Physical trauma


subject: CHEBI:30145

subject_name: lithium atom

object_name: small cell lung carcinoma


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: CHEBI:229778

object_name: T-B+ severe combined immunodeficiency due to gamma chain deficiency


subject: UniProtKB:P0A6Z1

subject_name: HSCA_ECOLI Chaperone protein HscA (sprot)


subject: PR:000007702


subject: PR:000022925

subject_name: chaperone protein HscA


subject: UMLS:C5555006

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5543883

object_name: eosinophilic esophagitis


subject: UMLS:C5543883

object_name: Eosinophilic infiltration of the esophagus


subject: CHEBI:64816

object_name: Stomach cancer


subject: CHEBI:64816

object_name: gastric cancer


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: UMLS:C5814342

subject_name: SerpinPC

object_name: hemophilia A


subject: UMLS:C5814342

object_name: hemophilia B


subject: UMLS:C5814342

object_name: hemophilia B leyden


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: T-Cell Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: T-cell large granular lymphocyte leukemia


subject: PUBCHEM.COMPOUND:58008990

object_name: T-cell prolymphocytic leukemia


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: EXCESS LMW-DNA


subject: UMLS:C4329313


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEBI:57694

object_name: endometriosis


subject: CHEBI:16243

subject_name: Quercetin


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: extranodal marginal zone B-cell lymphoma


subject: UMLS:C5700219

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: spinal muscular atrophy


subject: CHEBI:34385

object_name: proximal spinal muscular atrophy


subject: PR:000009996

subject_name: lymphocyte antigen 6K

object_name: carcinoma of esophagus


subject: PR:000009996

object_name: esophageal cancer


subject: PR:000009996

object_name: Childhood Esophageal Carcinoma


subject: PR:000009996

object_name: neoplasm of esophagus


subject: UNII:4O87Q44KNC

object_name: Hormone receptor positive malignant neoplasm of breast


subject: UMLS:C1306531

subject_name: Tham brand of tromethamine

object_name: cystic fibrosis


subject: CHEBI:9754

subject_name: Tromethamine


subject: PR:000001341

subject_name: dipeptidyl peptidase 4


subject: CHEBI:145431

subject_name: Indisulam

object_name: renal cell carcinoma


subject: CHEBI:145431

object_name: kidney neoplasm


subject: CHEBI:145431

object_name: kidney cancer


subject: UMLS:C0879271


subject: UMLS:C0879271


subject: UMLS:C0879271


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: childhood acute myeloid leukemia


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: lymphoid system disorder


subject: UMLS:C0919075

object_name: Lymphadenopathy


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: coronary atherosclerosis


subject: UNII:7N8K34P2XH

subject_name: Detomidine

object_name: coronary artery disorder


subject: UNII:7N8K34P2XH


subject: UMLS:C0127159

subject_name: MCI 186

object_name: Hepatic impairment


subject: CHEBI:31530

subject_name: Edaravone


subject: CHEBI:72296

subject_name: Apixaban

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:72296

object_name: obesity


subject: CHEBI:72296

object_name: Obesity, CTCAE


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: lung cancer


subject: UNII:T4RS462G19

object_name: lung neoplasm


subject: UNII:T4RS462G19

object_name: lung carcinoma


subject: CHEBI:231683

subject_name: Anakinra

object_name: Reactive hypoglycemia


subject: CHEBI:231683

object_name: Late dumping syndrome


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin


subject: PUBCHEM.COMPOUND:73151030


subject: UMLS:C2984025

subject_name: Ferinject

object_name: Anemia of pregnancy


subject: CHEBI:192761

subject_name: Iron sucrose


subject: UMLS:C0308803

subject_name: dexamethasone injection

object_name: post operative nausea and vomiting


subject: UMLS:C0498883

subject_name: Injection, haloperidol, up to 5 mg administered


subject: UMLS:C2987639

subject_name: Haloperidol Liquid Injection


subject: CHEBI:5613

subject_name: Haloperidol


subject: CHEBI:76842

object_name: Wound Infection


subject: CHEBI:76842

object_name: Wound Infection, CTCAE


subject: CHEBI:231674

object_name: adult lymphoma


subject: CHEBI:231674

object_name: lymphoma


subject: CHEBI:231674

object_name: pediatric lymphoma


subject: CHEBI:231674

object_name: prostate carcinoma


subject: CHEBI:231674

object_name: prostate cancer


subject: CHEBI:231674

object_name: pancreatic neoplasm


subject: CHEBI:231674

object_name: exocrine pancreatic carcinoma


subject: CHEBI:231674

object_name: malignant pancreatic neoplasm


subject: CHEBI:231674

object_name: ovarian cancer


subject: CHEBI:231674

object_name: ovarian neoplasm


subject: CHEBI:231674

object_name: ovarian carcinoma


subject: CHEBI:231674

object_name: Childhood Breast Carcinoma


subject: CHEBI:231674

object_name: breast carcinoma


subject: CHEBI:231674

object_name: breast cancer


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Pain, Procedural


subject: PUBCHEM.COMPOUND:9824461

object_name: Procedural anxiety


subject: UMLS:C2826229

object_name: metastatic colorectal cancer


subject: CHEBI:178199

subject_name: Sotorasib


subject: CHEBI:41423

subject_name: Celecoxib

object_name: HER2/Neu Negative


subject: CHEBI:41423

object_name: Early Stage Breast Carcinoma


subject: CHEBI:41423

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:41423

object_name: Estrogen Receptor Negative


subject: CHEBI:41423

object_name: Progesterone Receptor Negative


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:4026


subject: CHEBI:4026

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C0021735

subject_name: Viraferon

object_name: triple-negative breast carcinoma


subject: UMLS:C0021735

object_name: HER2/Neu Negative


subject: UMLS:C0021735

object_name: Early Stage Breast Carcinoma


subject: UMLS:C0021735


subject: UMLS:C0021735

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C0021735


subject: UMLS:C0021735

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C0021735

object_name: Estrogen Receptor Negative


subject: UMLS:C0021735

object_name: Progesterone Receptor Negative


subject: PUBCHEM.COMPOUND:135537060

subject_name: Rintatolimod

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:135537060

object_name: HER2/Neu Negative


subject: PUBCHEM.COMPOUND:135537060

object_name: Early Stage Breast Carcinoma


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135537060

object_name: Estrogen Receptor Negative


subject: PUBCHEM.COMPOUND:135537060

object_name: Progesterone Receptor Negative


subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD

object_name: triple-negative breast carcinoma


subject: UNII:94325AJ25N

object_name: HER2/Neu Negative


subject: UNII:94325AJ25N

object_name: Early Stage Breast Carcinoma


subject: UNII:94325AJ25N

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UNII:94325AJ25N

object_name: Estrogen Receptor Negative


subject: UNII:94325AJ25N

object_name: Progesterone Receptor Negative


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: digestive system cancer


subject: CHEBI:64321

object_name: Nausea post chemotherapy


subject: UMLS:C1704263

subject_name: green tea extract

object_name: Type 2 diabetes mellitus with established diabetic nephropathy


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: CHEBI:82960

subject_name: Raltegravir

object_name: HBV coinfection


subject: CHEBI:63716

subject_name: TENOFOVIR


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: anxiety


subject: CHEBI:46195

object_name: anxiety disorder


subject: CHEBI:46195

object_name: Anxiety symptoms


subject: CHEBI:46195

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:46195

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:66919

object_name: breast carcinoma


subject: CHEBI:66919

object_name: breast cancer


subject: UMLS:C0376659

subject_name: Cancer Vaccines

object_name: Advanced Adenocarcinoma


subject: UMLS:C0376659

object_name: Recurrent Adenocarcinoma


subject: UMLS:C0376659

object_name: Adenocarcinoma, metastatic


subject: UMLS:C0376659

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C0376659

object_name: Recurrent Malignant Solid Neoplasm